What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 4 minute read Pharma Industry News Hope for bladder cancer patients? UroGen’s UGN-301 shows strong safety and clinical activity in early trial Find out how UroGen Pharma’s UGN-301 is offering new hope for bladder cancer patients with promising Phase 1 trial results. Read the latest developments here! byPallavi MadhirajuApril 27, 2025